Download PDF
Endoscopy 2009; 41(10): 855-860
DOI: 10.1055/s-0029-1215089
DDW highlights

© Georg Thieme Verlag KG Stuttgart · New York

Reflux disease and Barrett’s esophagus

A.  M.  Panossian1 , H.  C.  Wolfsen1
  • 1Division of Gastroenterology and Hepatology, Mayo Clinic Florida, Jacksonville, Florida, USA
Further Information

Publication History

Publication Date:
11 September 2009 (online)

Also available at
    Permissions and Reprints

Introduction

Digestive Disease Week (DDW) 2009 in Chicago featured several important presentations regarding the improved diagnosis of, detection of dysplasia in, and endoscopic therapy for Barrett’s disease. Among the 322 abstracts concerning gastroesophageal reflux disease (GERD) and Barrett’s esophagus (BE), there were several describing outstanding multicenter, controlled, randomized trials that were presented at plenary sessions.

References

  • 1 Wolfsen H C, Crook J E, Krishna M. et al . Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett’s esophagus.  Gastroenterology. 2008;  135 24-31
    CrossrefPubMedGoogle Scholar
  • 2 Sharma P, Bansal A, Hawes R H. et al . Detection of metaplasia (IM) and neoplasia in patients with Barrett’s esophagus (BE) using high-definition white light endoscopy (HD-WLE) versus narrow band imaging (NBI): a prospective, multi-center, randomized, crossover trial.  Gastrointest Endosc. 2009;  69 AB135
    PubMedGoogle Scholar
  • 3 Meining A, Vieth M, Rosch T. et al . Probe-based confocal endomicroscopy is equivalent to standard four-quadrant-stepwise biopsy technique for diagnosis of neoplasia arising from Barrett’s esophagus.  Gastroenterology. 2009;  136 A-130
    PubMedGoogle Scholar
  • 4 Wallace M B, Abrams J A, Bajbouj M. et al . Accuracy and inter-observer agreement of experts for probe-based confocal laser endomicroscopy detection of dysplasia in barrett’s esophagus.  Gastrointest Endosc. 2009;  69 AB351
    PubMedGoogle Scholar
  • 5 Wax A, Zhu Y, Terry N G. et al . Label-free nuclear morphology measurements of dysplasia in the EGDA rat model using angle-resolved low coherence interferometry.  Gastroenterology. 2009;  136 A-122
    PubMedGoogle Scholar
  • 6 DeVault K R, Leemis J D, Coe S G. et al . T1889 Short segment Barrett’s esophagus: variability of approach and diagnostic yield.  Gastroenterology. 2009;  136 A-594
    PubMedGoogle Scholar
  • 7 Shaheen N J, Sharma P, Overholt B F. et al . Radiofrequency ablation in Barrett’s esophagus with dysplasia.  N Engl J Med. 2009;  360 2277-2288
    CrossrefPubMedGoogle Scholar
  • 8 Van Vilsteren F G, Pouw R E, Seewald S. et al . A multi-centered randomized trial comparing stepwise radical endoscopic resection versus radiofrequency ablation for Barrett esophagus containing high-grade dysplasia and/or early cancer.  Gastrointest Endosc. 2009;  69 AB133-AB134
    PubMedGoogle Scholar
  • 9 Thomas T, Ayaru L, Lee E Y. et al . Extensive endomucosal resection (EMR) of Barrett’s esophagus (BE) with high-grade intraepithelial neoplasia (HGIN) or intramucosal carcinoma (IMC): efficacy, safety and factors predicting complete eradication.  Gastrointest Endosc. 2009;  69 AB340
    PubMedGoogle Scholar
  • 10 Canto M I, Gorospe E C, Shin E J. et al . Carbon dioxide (CO2) cryotherapy is a safe and effective treatment of Barrett’s esophagus (BE) with HGD/intramucosal carcinoma.  Gastrointest Endosc. 2009;  69 AB341
    PubMedGoogle Scholar
  • 11 Shaheen N J, Greenwald B D, Dumot J A. et al . Safety and efficacy of endoscopic spray cryotherapy for Barrett’s esophagus with high-grade dysplasia.  Gastrointest Endosc. 2009;  69 AB357
    PubMedGoogle Scholar
  • 12 Greenwald B D, Dumot J A, Abrams J A. et al . Endoscopic spray cryotherapy for esophageal cancer: safety and efficacy.  Gastrointest Endosc. 2009;  69 AB349
    PubMedGoogle Scholar
  • 13 Herrero L A, Pouw R E, Van Vilsteren F G. et al . What are the outcomes of endoscopic radiofrequency ablation for very long segments of Barrett esophagus containing neoplasia?.  Gastrointest Endosc. 2009;  69 AB116
    PubMedGoogle Scholar
  • 14 Panjehpour M, Overholt B F, Phan-Brooks M N. et al . Photodynamic therapy (PDT) for Barrett’s esophagus with dysplasia: long-term follow-up of gastroesophageal junction area is recommended.  Gastrointest Endosc. 2009;  69 AB339-AB340
    PubMedGoogle Scholar
  • 15 Shaheen N J, Bright S D, Madanick R D. et al . What is the efficacy of high-dose acid suppression in chronic cough? A randomized, double-blind, placebo-controlled trial.  Gastroenterology. 2009;  136 A-79
    PubMedGoogle Scholar
  • 16 Vaezi M F, Hagaman D D, Slaughter J C. et al . A randomized double-blind placebo-controlled study of acid suppression for isolated chronic postnasal drip.  Gastroenterology. 2009;  136 (5 Suppl 1) A-107
    PubMedGoogle Scholar
  • 17 Rosati R, Fumagalli U, Barbera R. et al . 456 Endoluminal fundoplication (ELF) for GERD – 12 month follow up.  Gastroenterology. 2009;  136 A-872
    PubMedGoogle Scholar
  • 18 Schreinemakers R, Smout A J, Schwartz M P. Four-year open-label follow-up of a randomized, placebo-controlled trial of endoscopic gastroplication (Endocinch) for the treatment of gastro-esophageal reflux disease (GERD). ASGE esophagus session.  Gastrointestinal Endosc. 2009;  69 AB342
    PubMedGoogle Scholar
  • 19 Almansa C, Cano S, DeVault K R. et al . S1862 Overlapping features between eosinophilic esophagitis and gastroesophageal reflux.  Gastroenterology. 2009;  136 A-280
    PubMedGoogle Scholar
  • 20 Wang K K, Fritcher E B, Halling K C. et al . The use of FISH in a multi-center blinded study to predict development of neoplasia in Barrett’s esophagus.  Gastroenterology. 2009;  136 A-157
    PubMedGoogle Scholar
  • 21 Kumaravel A, Lopez R, Brainard J. et al . Brush cytology versus endoscopic biopsy for surveillance of Barrett’s esophagus.  Gastroenterology. 2009;  136 A-157
    PubMedGoogle Scholar
  • 22 Wax A, Terry N G, Zhu Y. et al . T1881 Detection of dysplasia in Barrett’s esophagus with angle-resolved low coherence interferometry.  Gastroenterology. 2009;  136 A-592
    PubMedGoogle Scholar
  • 23 Westra W, Prasad G A, Halling K C. et al . Detection of high-grade dysplasia and esophageal adenocarcinoma using endoscopic mucosal resection in combination with fluorescence in situ hybridization.  Gastroenterology. 2009;  136 A-593
    PubMedGoogle Scholar
  • 24 Coco D, Goldblum J R, Hornick J L. et al . Interobserver variability in the diagnosis of crypt dysplasia in Barrett’s esophagus.  Gastroenterology. 2009;  136 A-593
    PubMedGoogle Scholar
  • 25 Doherty G A, Cheriyan D, Leyden J E. et al . Image recognition in the endoscopic diagnosis of Barrett’s oesophagus; a study of interobserver agreement and the impact of endoscopy experience.  Gastroenterology. 2009;  136 A-594
    PubMedGoogle Scholar
  • 26 Li Y, Dryden G W, Liu Q. et al . Endoscopic visualization of esophageal disease in rats after esophagoduodenal anastomosis.  Gastroenterology. 2009;  136 A-604
    PubMedGoogle Scholar
  • 27 Wani S B, Mathur S C, Curvers W L. et al . Inter-observer agreement among pathologists in the diagnosis of dysplasia in Barrett’s esophagus (BE): comparison between biopsy and EMR Specimens.  Gastroenterology. 2009;  136 A-732
    PubMedGoogle Scholar
  • 28 Longcroft-Wheaton G R, Duku M, Mead R. et al . Results from a large prospective series of acetic acid enhanced chromoendoscopy in evaluation of Barrett’s neoplasia: Is it time to change our practice?.  Gastrointest Endosc. 2009;  69 AB115
    PubMedGoogle Scholar
  • 29 Chaurand-Lara M, Sobrino-Cossio S R, Hernandez-Guerrero A. et al . Narrow band imaging to identify short and ultra-short segment Barrett’s esophagus in the presence of an irregular squamocolumnar junction.  Gastrointest Endosc. 2009;  69 AB354
    PubMedGoogle Scholar
  • 30 Wang K K, Badreddine R J, Tomizawa Y. et al . Endoscopic confocal laser microscopy with the probe system in Barretts esophagus.  Gastrointest Endosc. 2009;  69 AB349
    PubMedGoogle Scholar
  • 31 Wang K K, Brankley S M, Prasad G A. et al . Prospective randomized controlled trial of biomarkers to predict response to ablation therapy in Barrett’s esophagus (BE) with high grade dysplasia (HGD).  Gastroenterology. 2009;  136 A-157
    PubMedGoogle Scholar
  • 32 Lord R VN, Freeman A, Botelho N K. et al . Effect of Barryx halo radiofrequency ablation treatment on mRNA gene expression in Barrett’s esophagus with dysplasia.  Gastroenterology. 2009;  136 A-593
    PubMedGoogle Scholar
  • 33 Pouw R E, Van Vilsteren F G, Alvarez H errero. et al . Radiofrequency ablation for eradication of Barrett esophagus containing high-grade dysplasia or early cancer: a prospective series of 73 patients.  Gastrointest Endosc. 2009;  69 AB345-AB346
    PubMedGoogle Scholar
  • 34 Iizuku T, Kikuchi D, Hoteya S, Yahagi N. Outcomes of endoscopic submucosal dissection with flex knife for esophageal tumor in more than 300 consecutive cases.  Gastrointest Endosc. 2009;  69 AB341-AB342
    PubMedGoogle Scholar
  • 35 Shaheen N J, Sharma P, Overholt B F. et al . How durable is the reversion to neosquamous epithelium in subjects undergoing radiofrequency ablation for dysplastic Barrett’s esophagus? Two year follow-up of the AIM-dysplasia randomized sham-controlled trial.  Gastroenterology. 2009;  136 A-158
    PubMedGoogle Scholar
  • 36 Adler D C, Zhou C, Tsai T H. et al . Endoscopic three-dimensional optical coherence tomography confirms squamous epithelialization following radiofrequency ablation for Barrett’s esophagus.  Gastroenterology. 2009;  136 A-595
    PubMedGoogle Scholar
  • 37 Dunn J M, Mackenzie G D, Oukrif D. et al . DNA ploidy as a prognostic biomarker after ala photodynamic therapy for high grade dysplasia in Barrett’s oesophagus.  Gastroenterology. 2009;  136 A-49
    PubMedGoogle Scholar
  • 38 Lyday W, Corbett F S, Kuperman D A. et al . Endoscopic radiofrequency ablation of Barrett’s esophagus: safety and efficacy outcomes in 429 patients treated in a multi-center community practice registry.  Gastrointest Endosc. 2009;  69 AB114
    PubMedGoogle Scholar
  • 39 Pech O, Manner H, May A. et al . Endoscopic therapy in 1059 patients with high grade dysplasia and early adenocarcinoma in Barrett’s esophagus – lessons we have learned.  Gastrointest Endosc. 2009;  69 AB114-AB115
    PubMedGoogle Scholar
  • 40 Allison H, Banchs M A, Guelrud M. Barrett’s esophagus ablation with multipolar electrocoagulation; long term follow-up.  Gastrointest Endosc. 2009;  69 AB115
    PubMedGoogle Scholar
  • 41 Haringsma J, van Heel N C, Kuipers E J. Endoscopic ablation of early cancer in Barrett’s esophagus: long-term results of mucosal resection followed by photodynamic therapy.  Gastrointest Endosc. 2009;  69 AB345
    PubMedGoogle Scholar
  • 42 Singh M, Wani S B, Rastogi A. et al . Is proton pump inhibitor (PPI) use associated with a lower prevalence of Barrett’s esophagus (BE) in patients with chronic GERD?.  Gastroenterology. 2009;  136 A-595
    PubMedGoogle Scholar
  • 43 Razjouyan H, Nasseri-Moghaddam S, Ardekani B A. et al . Prevalence of columnar lined esophagus among Iranian GERD patients and the clinical correlations.  Gastroenterology. 2009;  136 A-594
    PubMedGoogle Scholar
  • 44 Ganz R A, Bonavina L, DeMeester T R. et al . Magnetic sphincter augmentation is safe and effective for the long-term treatment of gastroesophageal reflux disease (GERD).  Gastroenterology. 2009;  136 A-739
    PubMedGoogle Scholar
  • 45 Broeders J A, Rijnhart-de J ong, Draaisma W A. et al . Ten-year outcome of laparoscopic and conventional nissen fundoplication: randomized clinical trial.  Gastroenterology. 2009;  136 A-740
    PubMedGoogle Scholar
  • 46 Liu J J, Stenson T H, Thiesen A. Augmenting lower esophageal sphincter function and anatomy with a novel intraluminal therapy.  Gastroenterology. 2009;  136 A-740
    PubMedGoogle Scholar
  • 47 Boeckxstaens G E, Denison H, Ruth M. et al . Effect of AZD3355, a novel GABAB agonist, on reflux and lower esophageal sphincter function in patients with GERD with symptoms despite proton pump inhibitor treatment.  Gastroenterology. 2009;  136 A-433
    PubMedGoogle Scholar
  • 48 Bafutto M, Leite N V, Filho J R. Effects of combined therapy with esomeprazol and tegaserod in patients with extra-esophageal GERD not responsive to esomeprazol.  Gastroenterology. 2009;  136 A-434
    PubMedGoogle Scholar
  • 49 Cobell W J, Gleich G J, Thomas K. et al . Eosinophil degranulation differentiates eosinophilic esophagitis (EoE), possible EoE and GERD patients.  Gastroenterology. 2009;  136 A-279
    PubMedGoogle Scholar
  • 50 Poh C H, Gasiorowska A, Navarro-Rodriguez T. et al . Eosinophilic esophagitis is uncommon in male-enriched patient population with refractory heartburn.  Gastroenterology. 2009;  136 A-281
    PubMedGoogle Scholar
  • 51 Sá C C, Moraes-Filho J P, Eisig J N. et al . Low prevalence of eosinophilic esophagitis in patients with refractory gastroesophageal reflux disease. a prospective study.  Gastroenterology. 2009;  136 A-282
    PubMedGoogle Scholar
  • 52 Kovalak M, Teman C J, Thomas K. et al . Histologic differences between eosinophilic esophagitis and reflux: something to hang your hat on.  Gastroenterology. 2009;  136 A-284
    PubMedGoogle Scholar
  • 53 Foltz C, Gerson L B. Effect of intravenous sedation on Bravo pH monitoring.  Gastrointest Endosc. 2009;  69 AB340-AB341
    PubMedGoogle Scholar

H. C. WolfsenMD 

Mayo Clinic Florida

4500 San Pablo Road
Jacksonville, Florida 32224
USA

Fax: +1-904-953-7260

Email: wolfsen.herbert@mayo.edu